 |
市场调查报告书
商品编码
1190055
生物活性伤口敷料市场——增长、趋势和预测 (2023-2028)Bioactive Wound Dressing Market - Growth, Trends, and Forecasts (2023 - 2028) |
||||||
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
在预测期内，生物活性伤口敷料市场预计将以 11% 的复合年增长率增长。
COVID-19 大流行影响了生物活性伤口敷料市场和整个医疗保健行业，由于世界各国政府实施的社会疏远措施，医院和医疗服务都在萎缩。 COVID-19 大流行影响了全球经济，并显着影响了世界各地医院对非 COVID-19 患者的综合医院护理能力。 Uptodate Co., Ltd. 发表的一篇于 2022 年 6 月更新的论文指出，在 COVID-19 大流行期间，本应被视为基本护理的伤口护理的提供发生了变化。 在大流行期间，重点是伤口护理，以尽量减少住院和手术并防止严重的伤口并发症，而不是伤口的完全癒合。 可用生物活性伤口敷料服务的减少受到 COVID-19 大流行的负面影响，但在过去两年中已经恢復并实现强劲增长。
生物活性伤口敷料市场受到技术进步、人口老龄化、慢性伤口负担增加以及与传统伤口癒合治疗相关的挑战的推动。 2021 年 3 月发表在《伤口护理进展杂誌》上的一篇论文发现，慢性伤口会影响大约 2.5% 的美国人口的生活质量 (QoL)，这使得伤口护理管理对美国医疗保健部门至关重要。有人指出，它具有显着的经济影响。 慢性伤口在老年人群中最为常见。 随着美国人口老龄化的加剧，慢性伤口的发生率预计会增加，这也将推动所研究市场的增长。 根据世界银行 2022 年报告，欧盟的外科手术数量（每 100,000 人）为 11,075 次。 欧洲手术数量的增加直接促进了长期研究市场的增长，因为手术疤痕也在增加。 因此，随着手术数量的增加，预计在预测期内所研究的市场将增长。
然而，不断上涨的治疗成本和不利的报销政策是阻碍生物活性伤口敷料市场增长的一些因素。
生物活性伤口敷料市场的趋势
预计在预测期内市场细分将占据很大份额
各种外伤和烧伤的发病率不断增加是推动采用伤口敷料的主要因素之一。 根据 2021 年 10 月发表的《外科研究杂誌》的数据，非洲记录在案的烧伤总数为 44,369 人，其中男性的平均比例为 56%。 烧伤 (61%) 是最常见的伤害原因，其次是明火 (17%)。 同样，世卫组织 2022 年 1 月发布的数据表明，至少 33 个非洲、南美洲和西太平洋热带、亚热带和温带气候国家报告了布鲁里溃疡。 布鲁里溃疡的鑑别诊断包括热带噬菌体溃疡和由于动静脉功能不全引起的慢性腿部溃疡。 35% 的上肢、55% 的下肢和 10% 的其他部位发生这种疾病引起的病变。 有了这样的统计数据，伤口行业有望在不久的将来见证显着的增长。
此外，市场增长的因素之一是市场上的主要公司正在加紧努力以增加其存在。 例如，2022 年 1 月，Triad Life Sciences Inc. 签订了最终协议，将被 Convatec Group PLC 收购，以解决外科、慢性和烧伤伤口未满足的临床需求。
因此，由于上述因素，预计该细分市场在预测期内将出现显着增长。
北美预计在预测期内实现健康增长
北美生物活性伤口敷料市场预计将在全球占据重要的市场份额。 推动该地区市场的主要因素是适应快速老龄化社会的先进医疗体系、高糖尿病人口和创新。 糖尿病的患病率近年来有所增加，许多报告预测未来还会进一步增加。 例如，根据国际糖尿病联合会第 10 版糖尿病地图集，2021 年美国约有 3220 万人患有糖尿病，预计到 2045 年这一数字将上升到 3630 万。 根据加拿大糖尿病协会 (CDA) 的数据，到 2021 年，加拿大将有大约 1150 万人被诊断出患有糖尿病。 截至 2021 年，估计约有 29% 的加拿大人口易患糖尿病，包括确诊病例和未确诊病例。 随着日本糖尿病患者数量的增加，预计糖尿病溃疡患者的数量也会增加。 同样，《足部杂誌》2022 年 2 月的一篇文章指出，美国近 67% 的下肢截肢与糖尿病有关。 该国大量糖尿病足溃疡病例可能会推动市场增长。 因此，预计该行业在预测期内将出现显着增长。
生物活性伤口敷料市场的竞争分析
生物活性伤口敷料市场较为分散且竞争激烈。 主要市场参与者包括 3M、Convatec Group PLC、Monlnlycke Health Care AB、Smith & Nephew PLC、B. Braun SE。 此外，公司专注于行业合作、合併、收购和合作伙伴关係，以增加他们在所研究市场中的影响力。
其他福利。
- Excel 格式的市场预测 (ME) 表
- 三个月的分析师支持
内容
第一章介绍
- 研究假设和市场定义
- 调查范围
第二章研究方法论
第 3 章执行摘要
第四章市场动态
- 市场概览
- 市场驱动力
- 增加慢性伤口和相关疾病的负担
- 生物活性伤口敷料的进展
- 市场製约因素
- 缺乏适当的报销
- 波特的五力分析
- 新进入者的威胁
- 买方/消费者议价能力
- 供应商的议价能力
- 替代品的威胁
- 竞争公司之间的敌对关係
第 5 章市场细分（基于价值的市场规模：百万美元）
- 按产品分类
- 水胶体
- 藻酸盐敷料
- 皮肤替代品
- 抗菌敷料
- 其他产品
- 通过使用
- 伤口
- 伯恩斯
- 溃疡
- 其他用途
- 按地区
- 北美
- 美国
- 加拿大
- 墨西哥
- 欧洲
- 德国
- 英国
- 法国
- 意大利
- 西班牙
- 其他欧洲地区
- 亚太地区
- 中国
- 日本
- 印度
- 澳大利亚
- 韩国
- 其他亚太地区
- 中东和非洲
- 海湾合作委员会
- 南非
- 其他中东地区
- 南美洲地区
- 巴西
- 阿根廷
- 其他南美洲
- 北美
第六章竞争格局
- 公司简介
- 3M
- B. Braun SE
- BSN Medical（Essity）
- Convatec Group PLC
- Covalon Technologies Ltd
- DermaRite Industries LLC
- Hollister Incorporated
- Integra LifeSciences Holdings Corporation
- Johnson & Johnson
- Medtronic PLC
- Monlnlycke Health Care AB
- Smith & Nephew PLC
第7章 市场机会今后动向
The bioactive wound dressing market is expected to register a CAGR of 11% during the forecast period.
The COVID-19 outbreak impacted the bioactive wound dressing market and the overall healthcare sector, as hospitals and healthcare services were reduced due to social distancing measures taken by governments worldwide. The COVID-19 pandemic affected the global economy and greatly impacted the functioning of general hospital care for non-COVID-19 patients in hospitals globally. The article presented by UpToDate Inc., updated in June 2022, indicated that the delivery of wound care, which should be regarded as an essential medical service, shifted during the COVID-19 pandemic. During the pandemic, significant importance was placed on wound care to prevent serious wound complications by minimizing hospitalization and surgery rather than completing wound healing. The reduction in the available bioactive wound dressing services was adversely impacted by the COVID-19 pandemic but has recovered in the two years to post strong growth.
The bioactive wound dressing market is driven by advancements in technology, the growing aging population, the rising burden of chronic wounds, and problems associated with conventional wound healing procedures. An article published in the Journal of Advances in Wound Care in March 2021 indicated that chronic wounds impact the quality of life (QoL) of nearly 2.5% of the US population and that wound care management has an important economic impact on the US healthcare sector. Chronic wounds are most commonly seen in the elderly population of the nation. With the growing geriatric population in United States, the incidence of chronic wounds is expected to increase, thereby aiding the growth of the market studied. According to the World Bank Report 2022, there were 11,075 surgical procedures (per 100,000 population) in the European Union. The rising number of surgeries in Europe has been directly contributing to the growth of the market studied in the long run, as wounds have also been increasing due to surgeries. Therefore, with the rising volume of surgical procedures, the market studied is expected to grow over the forecast period.
However, the high cost of treatment and unfavorable reimbursement policies are a few factors hindering the growth of the bioactive wound dressing market.
Bioactive Wound Dressing Market Trends
Wounds Segment is Expected to Hold a Significant Market Share over the Forecast Period
The increasing cases of different traumatic wounds and burns are one of the major factors driving the adoption of wound dressing. According to the Journal of Surgical Research data published in October 2021, the total number of burn patients recorded was 44,369 in Africa, of which the mean proportion of males was 56%. The most common cause of injury was scalding (61%), followed by open flame (17%). Similarly, WHO data published in January 2022 stated that at least 33 countries with tropical, subtropical, and temperate climates had reported Buruli ulcers in Africa, South America, and Western Pacific regions. Differential diagnoses of Buruli ulcers include tropical phagedenic ulcers and chronic lower leg ulcers due to arterial and venous insufficiency. The lesions due to this disease occur 35% on the upper limbs, 55% on the lower limbs, and 10% on other parts of the body. Such statistics indicate that the wounds segment is expected to witness notable growth in the near future.
Moreover, rising initiatives by key players in the market to grow their presence is another factor in the market's growth. For instance, in January 2022, Triad Life Sciences Inc. entered into a formal agreement to be acquired by Convatec Group PLC to address unmet clinical requirements in surgical wounds, chronic wounds, and burns.
Hence, owing to the aforementioned factors, the segment is expected to witness significant growth over the forecast period.
North America is Expected to Witness Healthy Growth over the Forecast Period
The North American bioactive wound dressing market is projected to have a significant market share worldwide. The major factors driving the market in the region are the rapidly growing aging population, the high diabetic population, and the developed healthcare system, which adapts to novel innovations. The prevalence of diabetes has increased in recent years, and many reports have predicted this prevalence to increase further in the future. For instance, according to the International Diabetes Federation Diabetes Atlas Tenth edition, in 2021, around 32.2 million people in United States had diabetes, and this is projected to grow to 36.3 million by 2045. As per the Canadian Diabetes Association (CDA), in 2021, there were around 11.5 million people in Canada diagnosed with diabetes. As of 2021, around 29% of the Canadian population was estimated to be susceptible to diabetes, which included both diagnosed and undiagnosed cases. The rising number of diabetic cases in the nation is expected to increase the number of diabetic ulcer cases. Similarly, an article published in the Journal of Foot in February 2022 indicated that nearly 67% of leg amputations in United States are associated with diabetes. Many cases of diabetic foot ulcers in the nation are likely to propel the market's growth. Thus, owing to the aforementioned factors, the segment is expected to show significant growth over the forecast period.
Bioactive Wound Dressing Market Competitive Analysis
The bioactive wound dressing market is moderately fragmented and competitive. The key market players include 3M, Convatec Group PLC, Monlnlycke Health Care AB, Smith & Nephew PLC, and B. Braun SE, among others. Furthermore, companies focus on industry collaborations, mergers, acquisitions, and partnerships to enhance their presence in the market studied.
Additional Benefits:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
TABLE OF CONTENTS
1 INTRODUCTION
- 1.1 Study Assumptions and Market Definition
- 1.2 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
- 4.1 Market Overview
- 4.2 Market Drivers
- 4.2.1 Growing Burden of Chronic Wounds and Associated Diseases
- 4.2.2 Advancements in Bioactive Wound Dressings
- 4.3 Market Restraints
- 4.3.1 Lack of Proper Reimbursement
- 4.4 Porter's Five Force Analysis
- 4.4.1 Threat of New Entrants
- 4.4.2 Bargaining Power of Buyers/Consumers
- 4.4.3 Bargaining Power of Suppliers
- 4.4.4 Threat of Substitute Products
- 4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION (Market Size by Value - USD million)
- 5.1 By Product
- 5.1.1 Hydrocolloids
- 5.1.2 Alginate Dressing
- 5.1.3 Skin Substitutes
- 5.1.4 Antimicrobial Dressing
- 5.1.5 Other Products
- 5.2 By Application
- 5.2.1 Wounds
- 5.2.2 Burns
- 5.2.3 Ulcers
- 5.2.4 Other Applications
- 5.3 Geography
- 5.3.1 North America
- 5.3.1.1 United States
- 5.3.1.2 Canada
- 5.3.1.3 Mexico
- 5.3.2 Europe
- 5.3.2.1 Germany
- 5.3.2.2 United Kingdom
- 5.3.2.3 France
- 5.3.2.4 Italy
- 5.3.2.5 Spain
- 5.3.2.6 Rest of Europe
- 5.3.3 Asia-Pacific
- 5.3.3.1 China
- 5.3.3.2 Japan
- 5.3.3.3 India
- 5.3.3.4 Australia
- 5.3.3.5 South Korea
- 5.3.3.6 Rest of Asia-Pacific
- 5.3.4 Middle East and Africa
- 5.3.4.1 GCC
- 5.3.4.2 South Africa
- 5.3.4.3 Rest of Middle East and Africa
- 5.3.5 South America
- 5.3.5.1 Brazil
- 5.3.5.2 Argentina
- 5.3.5.3 Rest of South America
- 5.3.1 North America
6 COMPETITIVE LANDSCAPE
- 6.1 Company Profiles
- 6.1.1 3M
- 6.1.2 B. Braun SE
- 6.1.3 BSN Medical (Essity)
- 6.1.4 Convatec Group PLC
- 6.1.5 Covalon Technologies Ltd
- 6.1.6 DermaRite Industries LLC
- 6.1.7 Hollister Incorporated
- 6.1.8 Integra LifeSciences Holdings Corporation
- 6.1.9 Johnson & Johnson
- 6.1.10 Medtronic PLC
- 6.1.11 Monlnlycke Health Care AB
- 6.1.12 Smith & Nephew PLC
